Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA31205
Max Phase: Preclinical
Molecular Formula: C37H40N2O12
Molecular Weight: 704.73
Molecule Type: Small molecule
Associated Items:
ID: ALA31205
Max Phase: Preclinical
Molecular Formula: C37H40N2O12
Molecular Weight: 704.73
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOC(=O)CC[C@H](NC(=O)c1ccc(N[C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)cc1)C(=O)OCC
Standard InChI: InChI=1S/C37H40N2O12/c1-5-47-30(40)12-11-25(36(43)48-6-2)39-35(42)19-7-9-21(10-8-19)38-33-23-16-27-26(50-18-51-27)15-22(23)31(32-24(33)17-49-37(32)44)20-13-28(45-3)34(41)29(14-20)46-4/h7-10,13-16,24-25,31-33,38,41H,5-6,11-12,17-18H2,1-4H3,(H,39,42)/t24-,25-,31+,32-,33+/m0/s1
Standard InChI Key: WNRMXJFDWZLAJB-FVNZCJSRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 704.73 | Molecular Weight (Monoisotopic): 704.2581 | AlogP: 4.23 | #Rotatable Bonds: 13 |
Polar Surface Area: 177.18 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.33 | CX Basic pKa: 2.64 | CX LogP: 3.21 | CX LogD: 3.21 |
Aromatic Rings: 3 | Heavy Atoms: 51 | QED Weighted: 0.17 | Np Likeness Score: 0.70 |
1. Cho SJ, Tropsha A, Suffness M, Cheng YC, Lee KH.. (1996) Antitumor agents. 163. Three-dimensional quantitative structure-activity relationship study of 4'-O-demethylepipodophyllotoxin analogs using the modified CoMFA/q2-GRS approach., 39 (7): [PMID:8691468] [10.1021/jm9503052] |
2. Xiao Z, Xiao YD, Feng J, Golbraikh A, Tropsha A, Lee KH.. (2002) Antitumor agents. 213. Modeling of epipodophyllotoxin derivatives using variable selection k nearest neighbor QSAR method., 45 (11): [PMID:12014968] [10.1021/jm0105427] |
3. Zhang YL, Guo X, Cheng YC, Lee KH.. (1994) Antitumor agents. 148. Synthesis and biological evaluation of novel 4 beta-amino derivatives of etoposide with better pharmacological profiles., 37 (4): [PMID:8120864] [10.1021/jm00030a003] |
Source(1):